Vivimed Labs Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants)Regulations, 2018'.
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs has submitted to the stock exchanges a certificate from its Registrar and Share Transfer Agent (RTA), Aarthi Consultants Private Limited, for the quarter ended 30th June 2025. The RTA has confirmed compliance with SEBI's Regulation 74(5), which means it has completed all dematerialisation-related actions within 15 days of receiving share certificates from depository participants during 1st April 2025 to 30th June 2025. These actions include confirming dematerialised securities are listed, mutilating and cancelling physical certificates, and updating the depository's name as the registered owner in company records. This is a routine procedural filing required under SEBI depository regulations and does not involve any business or financial decision.
This is a standard regulatory compliance filing with no material impact on shareholders, operations, or stock price. It simply confirms that the company's RTA has properly processed share dematerialisation requests during the April–June 2025 quarter.